| RKDA |
Arcadia Biosciences, Inc. |
92%
|
Reciprocal relationship from RKDA graph: On March 28, 2025, Arcadia entered into an agreement with Bioceres Crop Solutions Corp. ("BIOX") pursuant to which BIOX agreed to transfer to the Company all … |
| SYNGENTA |
SYNGENTA |
92%
|
Our subsidiary Rizobacter will act as the exclusive supplier to Syngenta for products under the agreement. |
| MLEC |
Moolec Science SA |
80%
|
Reciprocal relationship from MLEC graph: See " Item 7. Major Shareholders and Related Party Transactions—B. Related Party Transactions—Convertible Note issued to Bioceres Crop Solutions Corp . |
| FMC |
FMC Corporation |
72%
|
improving nutrient availability, uptake or use efficiency, tolerance to abiotic stress and consequent growth development, quality, or yield. Biostimulants are among the most rapidly growing categorie… |
| FMC |
FMC Corporation |
72%
|
Reciprocal relationship from FMC graph: Reciprocal relationship from BIOX graph: improving nutrient availability, uptake or use efficiency, tolerance to abiotic stress and consequent growth developme… |
| MLEC |
Moolec Science SA |
72%
|
Item 4. Information on the Company — B. Business Overview — Joint Ventures and Key Collaborations ” for more details on these agreements. Licensing to Third Parties We also rely on third-party channe… |
| BAYER-BASF-CORTEVA-SYNGENTA-AG-UPL-LIMITED |
BAYER-BASF-CORTEVA-SYNGENTA-AG-UPL-LIMITED |
62%
|
improving nutrient availability, uptake or use efficiency, tolerance to abiotic stress and consequent growth development, quality, or yield. Biostimulants are among the most rapidly growing categorie… |
| BCS-HOLDING-INC |
BCS-HOLDING-INC |
62%
|
ted States, regulatory approval is generally necessary before genetically modified or similarly regulated products can be imported or commercialized. The regulatory environment in these jurisdictions… |
| BCS-MERGER-SUB-INC |
BCS-MERGER-SUB-INC |
62%
|
closing of the merger (the “Pro Farm Merger”) with Pro Farm Group, Inc. (formerly Marrone Bio Innovations Inc.), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) dated March 16, … |
| BIOCERES-GROUP |
BIOCERES-GROUP |
62%
|
Item 4. Information on the Company — B. Business Overview — Joint Ventures and Key Collaborations ” for more details on these agreements. Licensing to Third Parties We also rely on third-party channe… |
| BIOCERES-GROUP-LIMITED |
BIOCERES-GROUP-LIMITED |
62%
|
echnologies to be applied to corn, with Natal committing to pay 15 % of the revenues generated from this technology. Since the issuance of the annual financial statements for the period ending June 3… |
| BIOCERES-GROUP-PLC |
BIOCERES-GROUP-PLC |
62%
|
echnologies to be applied to corn, with Natal committing to pay 15 % of the revenues generated from this technology. Since the issuance of the annual financial statements for the period ending June 3… |
| BIOCERES-GROUP-PLC-GENTLE-TECHNOLOGIES-CORP |
BIOCERES-GROUP-PLC-GENTLE-TECHNOLOGIES-CORP |
62%
|
Item 4. Information on the Company — B. Business Overview — Joint Ventures and Key Collaborations ” for more details on these agreements. Licensing to Third Parties We also rely on third-party channe… |
| BORROWINGS-THE-GROUP |
BORROWINGS-THE-GROUP |
62%
|
s its financial assets and liabilities at initial recognition at fair value and subsequently at amortized cost using the effective interest method. The Group has not irrevocably designated a financia… |
| COGENCY-GLOBAL-INC |
COGENCY-GLOBAL-INC |
62%
|
June 30, 2023, our total revenue, net profit and adjusted EBITDA for the year ended June 30, 2023 totaled US$420.1 million, US$20.2 million and US$81.2 million, respectively. Adjusted EBITDA is a non… |
| ESTIMATES-THE-GROUP |
ESTIMATES-THE-GROUP |
62%
|
s its financial assets and liabilities at initial recognition at fair value and subsequently at amortized cost using the effective interest method. The Group has not irrevocably designated a financia… |
| GENERAL-INFORMATION-BIOCERES-CROP-SOLUTIONS-CORP |
GENERAL-INFORMATION-BIOCERES-CROP-SOLUTIONS-CORP |
62%
|
079 Gain from a bargain purchase 8.5 — ( 1,032,327 ) — Provisions for contingencies 335,773 367,126 221,008 Allowance for impairment of trade debtors 7,123,716 753,428 1,327,385… |
| LIGHTJUMP-ACQUISITION-CORPORATION |
LIGHTJUMP-ACQUISITION-CORPORATION |
62%
|
Item 4. Information on the Company — B. Business Overview — Joint Ventures and Key Collaborations ” for more details on these agreements. Licensing to Third Parties We also rely on third-party channe… |
| MARRONE-BIO-INNOVATIONS-INC |
MARRONE-BIO-INNOVATIONS-INC |
62%
|
e have acquired or expect to acquire in the future. From time to time, we may acquire businesses, assets, or securities of companies that we believe will provide a strategic fit with our business, su… |
| MONSANTO-TECHNOLOGY-LLC |
MONSANTO-TECHNOLOGY-LLC |
62%
|
ur own projections of future demand. Because of the significant time it takes to produce commercial quantities of seeds, production decisions must be made well in advance of sales. An inaccurate fore… |
| MOOLEC-ACQUISITION-INC |
MOOLEC-ACQUISITION-INC |
62%
|
Item 4. Information on the Company — B. Business Overview — Joint Ventures and Key Collaborations ” for more details on these agreements. Licensing to Third Parties We also rely on third-party channe… |
| MOOLEC-SCIENCE-LIMITED |
MOOLEC-SCIENCE-LIMITED |
62%
|
Item 4. Information on the Company — B. Business Overview — Joint Ventures and Key Collaborations ” for more details on these agreements. Licensing to Third Parties We also rely on third-party channe… |
| MOOLEC-SCIENCE-LTD |
MOOLEC-SCIENCE-LTD |
62%
|
Item 4. Information on the Company — B. Business Overview — Joint Ventures and Key Collaborations ” for more details on these agreements. Licensing to Third Parties We also rely on third-party channe… |
| NASDAQ-STOCK-MARKET-LLC |
NASDAQ-STOCK-MARKET-LLC |
62%
|
ur own projections of future demand. Because of the significant time it takes to produce commercial quantities of seeds, production decisions must be made well in advance of sales. An inaccurate fore… |
| PRO-FARM-GROUP |
PRO-FARM-GROUP |
62%
|
fore, the Consolidated financial statements do not include any adjustments that would result if the Group were unable to recover the carrying amount of the above-mentioned assets through the generati… |
| PRO-FARM-GROUP-INC |
PRO-FARM-GROUP-INC |
62%
|
e have acquired or expect to acquire in the future. From time to time, we may acquire businesses, assets, or securities of companies that we believe will provide a strategic fit with our business, su… |
| PRO-FARM-MERGER-PRO-FARM-GROUP-INC |
PRO-FARM-MERGER-PRO-FARM-GROUP-INC |
62%
|
closing of the merger (the “Pro Farm Merger”) with Pro Farm Group, Inc. (formerly Marrone Bio Innovations Inc.), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) dated March 16, … |
| PROVISIONS-THE-GROUP |
PROVISIONS-THE-GROUP |
62%
|
ity. As regards to the mandatory conversion feature, as it is a contingent settlement provision, the Group decided to measure the liability component at initial recognition, based on its best estimat… |
| RASA-HOLDING-LLC |
RASA-HOLDING-LLC |
62%
|
079 Gain from a bargain purchase 8.5 — ( 1,032,327 ) — Provisions for contingencies 335,773 367,126 221,008 Allowance for impairment of trade debtors 7,123,716 753,428 1,327,385… |
| RIZOBACTER-USA-LLC |
RIZOBACTER-USA-LLC |
62%
|
079 Gain from a bargain purchase 8.5 — ( 1,032,327 ) — Provisions for contingencies 335,773 367,126 221,008 Allowance for impairment of trade debtors 7,123,716 753,428 1,327,385… |
